Common Contracts
3 similar Confidential Treatment contracts by Glycomimetics Inc
LICENSE AGREEMENTConfidential Treatment • October 31st, 2013 • Glycomimetics Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT dated as of the 7th day of October, 2011 (the “Agreement”) is made between GlycoMimetics, Inc., a Delaware corporation having a place of business at 401 Professional Drive, Suite 250, Gaithersburg, Maryland 20879 (“GMI”) and Pfizer Inc., a Delaware corporation having its principal place of business at 235 East 42nd Street, New York, New York 10017 (“Pfizer”).
LICENSE AGREEMENT between GLYCOMIMETICS, INC. and PFIZER INC. dated as of October 7, 2011Confidential Treatment • October 4th, 2013 • Glycomimetics Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT dated as of the 7th day of October, 2011 (the “Agreement”) is made between GlycoMimetics, Inc., a Delaware corporation having a place of business at 401 Professional Drive, Suite 250, Gaithersburg, Maryland 20879 (“GMI”) and Pfizer Inc., a Delaware corporation having its principal place of business at 235 East 42nd Street, New York, New York 10017 (“Pfizer”).
LICENSE AGREEMENT between GLYCOMIMETICS, INC. and PFIZER INC. dated as of October 7, 2011Confidential Treatment • August 21st, 2013 • Glycomimetics Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT dated as of the 7th day of October, 2011 (the “Agreement”) is made between GlycoMimetics, Inc., a Delaware corporation having a place of business at 401 Professional Drive, Suite 250, Gaithersburg, Maryland 20879 (“GMI”) and Pfizer Inc., a Delaware corporation having its principal place of business at 235 East 42nd Street, New York, New York 10017 (“Pfizer”).
